An immunomodulatory peptide studied for T-cell maturation and immune support.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 5 mg vial takes 0.5 mL of water for a clean 10 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 0.5 mg draws to |
|---|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL | 5 units |
| 10 mg | 1 mL | 10 mg/mL | 5 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 0.5 mg. At 10 mg/mL, that draws to 5 units on a U-100 insulin syringe.
Enhances T-cell maturation and function through thymic signaling and modulates cytokine production. It also supports innate immune response capacity.
Thymosin Alpha-1 is commonly taken in the morning.
Add 0.5 mL of bacteriostatic water to a 5 mg Thymosin Alpha-1 vial for a 10 mg/mL solution.
A common Thymosin Alpha-1 starting dose is 0.5 mg, which at 10 mg/mL draws to 5 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the Thymosin Alpha-1 vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.
Add 0.5 mL of bacteriostatic water to a 5 mg Thymosin Alpha-1 vial for a 10 mg/mL solution. A 0.5 mg dose then draws to 5 units on a U-100 insulin syringe.
Add 1 mL of bacteriostatic water to a 10 mg Thymosin Alpha-1 vial for a 10 mg/mL solution. A 0.5 mg dose then draws to 5 units on a U-100 insulin syringe.